Bexarotene targets autophagy and is protective against thromboembolic stroke in aged mice with tauopathy

Abstract excerpt

Stroke is a highly debilitating, often fatal disorder for which current therapies are suitable for only a minor fraction of patients. Discovery of novel, effective therapies is hampered by the fact that advanced age, primary age-related tauopathy or comorbidities typical to several types of dementing diseases are usually not taken into account in preclinical studies, which predominantly use young, healthy...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autophagy in Disease and Therapy
• Share to Neuroinflammation and Neurodegeneration Mechanisms
• Share to Neurological Disease Mechanisms and Treatments